Bank Of America Corp Gilead Sciences, Inc. Put Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $159,816 - $201,576	-2,400 Reduced 1.53%	154,200 $12.9 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $7.12 Million - $8.22 Million	-112,800 Reduced 41.87%	156,600 $10.7 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $4.48 Million - $5.46 Million	-62,600 Reduced 18.86%	269,400 $19.7 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $8.47 Million - $9.61 Million	115,600 Added 53.42%	332,000 $26.9 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $5.61 Million - $6.4 Million	-73,800 Reduced 25.43%	216,400 $16.7 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $17.4 Million - $19.9 Million	-225,600 Reduced 43.74%	290,200 $24.1 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $267,976 - $384,721	4,300 Added 0.84%	515,800 $44.3 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $5.22 Million - $5.96 Million	87,700 Added 20.69%	511,500 $31.6 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $52.8 Million - $59.5 Million	-915,100 Reduced 68.35%	423,800 $26.2 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $11.1 Million - $14 Million	192,500 Added 16.79%	1,338,900 $79.6 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $27.4 Million - $31.1 Million	421,900 Added 58.23%	1,146,400 $83.2 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $21.2 Million - $22.9 Million	313,400 Added 76.23%	724,500 $50.6 Million
Q2 2021 Sep 13, 2021	BUY	$63.47 - $69.35 $26.1 Million - $28.5 Million	411,100 New	411,100 $28.3 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.